Veeva Systems has earned a buy rating due to re-accelerated growth in its core business segments, including a 13% year-over-year increase in its Commercial Solutions subscriptions and a robust 19.3% growth in R&D and Quality segments. The company benefits from tailwinds such as CRM migration from Salesforce, early AI adoption, and stable demand in regulated life sciences markets. Upcoming catalysts include an Investor Day on November 5, expected to update long-term targets and Falcon AI progress, and Q3 FY27 earnings on December 2, which may further influence investor sentiment.
As of Nov 03, 2026 19:43 WIB, Veeva Systems (VEEV) trades at USD 303.51 on Pluang, showing a 1.14% decline in the past day. The stock holds a market cap of $49.71 billion and an enterprise value of $42.61 billion, with a typical holding period of 8 days among Pluang investors. This data highlights the stock's current market position alongside its ongoing growth narrative.
